Compare INMD & PHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INMD | PHR |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 854.5M | 759.0M |
| IPO Year | 2018 | 2019 |
| Metric | INMD | PHR |
|---|---|---|
| Price | $14.84 | $11.10 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 18 |
| Target Price | $17.33 | ★ $21.18 |
| AVG Volume (30 Days) | 411.9K | ★ 720.6K |
| Earning Date | 05-06-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 103.92 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $480,591,000.00 |
| Revenue This Year | $1.74 | $8.43 |
| Revenue Next Year | $3.26 | $5.10 |
| P/E Ratio | ★ $10.11 | $237.60 |
| Revenue Growth | N/A | ★ 14.48 |
| 52 Week Low | $12.72 | $7.77 |
| 52 Week High | $16.74 | $30.43 |
| Indicator | INMD | PHR |
|---|---|---|
| Relative Strength Index (RSI) | 43.98 | 42.71 |
| Support Level | $13.27 | $10.51 |
| Resistance Level | $15.25 | $11.22 |
| Average True Range (ATR) | 0.18 | 0.49 |
| MACD | -0.03 | -0.11 |
| Stochastic Oscillator | 22.18 | 18.87 |
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.